摘要
目的通过氯高血红素(Heroin)诱导伊马替尼耐药慢性髓系白血病(CML)细胞株K562/A02.IM中血红素加氧酶-1(HO-1)基因表达,探讨HO-1基因对伊马替尼耐药CML细胞增殖的影响,为治疗CML多药耐药及新药的开发提供思路和实验依据。方法采用RT—PCR法检测20例CML伊马替尼耐药患者骨髓细胞中HO-1基因的表达,半定量RT—PCR法和Westernblot法分别检测不同剂量Hemin处理K562/A02-IM细胞不同时间后HO-1的表达,通过AnnexinV/H双染色法检测细胞凋亡情况,采用MTT法检测Hemin诱导及锌原卟啉抑制HO-1表达与细胞存活率的关系。结果RT—PCR结果显示耐药患者骨髓细胞中HO-1基因阳性表达,半定量RT—PCR和Westernblot法显示,不同浓度的Heroin(0、10、20及40μmol/L)处理K562/AO2-IM细胞16h后,HO-1的表达量随Heroin浓度的升高而增加,存在剂量依赖关系,而20μmol/LHeroin分别处理K562/AO2-IM细胞0、8、16、24h后,HO-1的表达量在处理16h组最高。AnnexinV/PI法检测显示,0、10、20及40pmlol/LHemin作用于K562/AO2-IM细胞16h后细胞凋亡率分别为(17.61±0.01)%、(12.13±0.11)%、(7.94±0.03)%和(4.62±0.15)%,其抗凋亡的作用呈剂量依赖性;20pmol/LHemin作用K562/A02-IM细胞8、16及24h的细胞凋亡率分别为(14.72±0.05)%、(8.15±0.07)%和(16.37±0.13)%。MTT法检测显示与对照组相比,Hemin诱导K562/AO2-IM细胞HO-1基因表达促进了细胞的增殖,且作用存在剂量依赖关系;而锌原卟啉抑制HO-1的表达,促进了细胞的凋亡(P〈0.05)。结论CML伊马替尼耐药患者骨髓细胞HO-1基因阳性表达,HO-1是一种可诱导表达型基因,具有抗细胞凋亡及促进细胞增殖的作用,抑制HO-1表达可能成为治疗CML耐药的新方法。
Objective To investigate the effect of heine oxygenase-1 ( HO-1 ) expression on cell growth and apoptosis in imatinib resistant chronic myeloid leukemia (CML) cells (K562/A02-IM) , and explore the relationship between HO-1 gene and CML. Methods The expression of HO-1 in 20 drug-resistant CML patients was detected by RT-PCR. Different concentrations of heroin were used to induce HO-1 expres- sion of K562/A02-IM, HO-1 expression at different time was detected by RT-PCR and Western blot analysis. Cell apoptosis was detected by Annexin V/PI staining, and MTT assay was used to detect viability of K562/ A02-1M cells after induction or inhibition of HO-1 gene by heroin and zinc protoporphyrin (ZPP). Results RT-PCR showed that HO-1 was expressed in the bone marrow mononuclear cells (BMMNCs). When treated with heroin at different concentrations (0, 10, 20, 40 μmol/L) for 16 h, the expression of HO-1 in K562/ AO2-IM was increased in a dose-dependent manner, and peaked at 20 μmot/L of hemin for 16 h. The apoptosis rates were (17.61 ±0.01)% , (12.13±0.11)% , (7.94 ±0.03)% and (4.62±0.15)% at 0,10, 20 and40 Ixmol/L of hemin respectively for 16 h and were (14.7±0.05)% , (8. 1±0.07)% and (16.3 ± 0.13)% at 20μmol/L of hemin treatment for 8,16, and 24 h respectively. Hemin induced apoptosis of K562/AO2-IM cells in a dose-dependent manner. The expression of HO-I was induced in K562/AO2-IM cells in a dose-dependent manner, and the survival of K562/AO2-IM cells was significantly increased as compared to that of control group. When HO-1 was inhibited by ZPP, the ceils survival was sharply decreased compared to that of the control group (P 〈0.05). Conclusion HO-1 was expressed in the BMMNCs. It is a kind of molecules whose expression can be induced and can promote the growth of drug-resistant cells. Inhibition of HO-1 expression probably be used for the treatment of drug-resistant CML.
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2011年第6期388-391,共4页
Chinese Journal of Hematology
基金
国家自然科学基金(30760276、30460127、81070444)
贵州省科技基础平台专项资金(黔科平台[2009]4007)